litlas
Log inCreate account

Lars Farde

Active 1985–2023

168
Papers
25,527
Citations
96
h-index
160
i10-index

Citations

Citations per year for Lars Farde1951: 1 citations1965: 1 citations1985: 1 citations1986: 17 citations1987: 25 citations1988: 56 citations1989: 58 citations1990: 45 citations1991: 77 citations1992: 73 citations1993: 111 citations1994: 67 citations1995: 123 citations1996: 127 citations1997: 168 citations1998: 143 citations1999: 196 citations2000: 157 citations2001: 194 citations2002: 197 citations2003: 239 citations2004: 172 citations2005: 206 citations2006: 267 citations2007: 218 citations2008: 264 citations2009: 287 citations2010: 251 citations2011: 223 citations2012: 226 citations2013: 222 citations2014: 169 citations2015: 192 citations2016: 174 citations2017: 136 citations2018: 126 citations2019: 391 citations2020: 391 citations2021: 387 citations2022: 314 citations2023: 222 citations2024: 250 citations2025: 128 citations2026: 3 citations1952–1964: no citations, so these years are not shown1966–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,918 citing papers, 27.6% of this breakdownUnited Kingdom: 670 citing papers, 9.7% of this breakdownGermany: 538 citing papers, 7.8% of this breakdownSweden: 530 citing papers, 7.6% of this breakdownCanada: 434 citing papers, 6.3% of this breakdownChina: 254 citing papers, 3.7% of this breakdownJapan: 222 citing papers, 3.2% of this breakdownFrance: 215 citing papers, 3.1% of this breakdownItaly: 213 citing papers, 3.1% of this breakdownNetherlands: 211 citing papers, 3% of this breakdownAustralia: 176 citing papers, 2.5% of this breakdownDenmark: 149 citing papers, 2.1% of this breakdown
0%27.6%Other 20.3%

Institutions

Fields

  • Medicine44.4%
  • Neuroscience37%
  • Psychology7%
  • Biochemistry, Genetics and Molecular Biology7%
  • Computer Science0.8%
  • Immunology and Microbiology0.8%
  • Other3%

Topics

  • Neurotransmitter Receptor Influence on Behavior9.3%
  • Schizophrenia research and treatment6%
  • Neuroscience and Neuropharmacology Research5.3%
  • Functional Brain Connectivity Studies5.2%
  • Receptor Mechanisms and Signaling3.3%
  • Neural and Behavioral Psychology Studies3.2%
  • Other67.7%

Coauthors

All papers

Open in search
  1. Preclinical Comparison of the Blood–brain barrier Permeability of Osimertinib with Other EGFR TKIs

    Authors: Nicola Colclough, Kan Chen, Peter Johnström, Nicole Strittmatter, Yumei Yan, Gail L. Wrigley, Magnus Schou, Richard J. A. Goodwin, Katarina Varnäs, Sally J. Adua, Minghui Zhao, Don X. Nguyen, Gareth Maglennon, Peter Barton, James Atkinson, Lin Zhang, Annika Janefeldt, Joanne Wilson, Aaron Smith, Akihiro Takano, Ryosuke Arakawa, Mikhail Kondrashov, Jonas Malmquist, Evgeny Revunov, Ana Vázquez‐Romero, Mohammad Mahdi Moein, Albert D. Windhorst, Natasha A. Karp, M. Raymond V. Finlay, Richard A. Ward, James Yates, Paul D. Smith, Lars Farde, Zack Cheng, Darren A.E. Cross - Clinical Cancer Research 2020 cited by 233

  2. Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson’s disease

    Authors: Aurelija Jučaitė, Per Svenningsson, Juha O. Rinne, Zsolt Cselényi, Katarina Varnäs, Peter Johnström, Nahid Amini, Anna K. Kirjavainen, Semi Helin, Margaret Minkwitz, Alan R. Kugler, Joel A. Posener, Samantha L. Budd, Christer Halldin, Andrea Varrone, Lars Farde - Brain 2015 cited by 222

  3. Effects of age, BMI and sex on the glial cell marker TSPO — a multicentre [11C]PBR28 HRRT PET study

    Authors: HRRT [11C ]PBR28 study group, Jouni Tuisku, Pontus Plavén‐Sigray, Edward Gaiser, Laura Airas, Haidar Al‐Abdulrasul, Anna Brück, Richard E. Carson, Ming-Kai Chen, Kelly Cosgrove, Laura L. Ekblad, Irina Esterlis, Lars Farde, Anton Forsberg, Christer Halldin, Semi Helin, Eva Kosek, Mats Lekander, Noora Lindgrén, Päivi Marjamäki, Eero Rissanen, Marcus Sucksdorff, Andrea Varrone, Karin Collste, Jean‐Dominique Gallezot, Ansel T. Hillmer, Yiyun Huang, C. Olgart Höglund, Jarkko Johansson, Aurelija Jučaitė, Jon Lampa, Nabeel Nabulsi, Brian Pittman, Christine Sandiego, Per Stenkrona, Juha O. Rinne, David Matuskey, Simon Červenka - European Journal of Nuclear Medicine and Molecular Imaging 2019 cited by 115

  4. The correlative triad among aging, dopamine, and cognition: Current status and future prospects

    Authors: Lars Bäckman, Lars Nyberg, Ulman Lindenberger, Shu Li, Lars Farde - Neuroscience & Biobehavioral Reviews 2006 cited by 790

  5. Meta-analysis of cognitive performance in drug-naïve patients with schizophrenia

    Authors: Helena Fatouros‐Bergman, Simon Červenka, Lena Flyckt, Gunnar Edman, Lars Farde - Schizophrenia Research 2014 cited by 271

  6. Clinical Validation of 18F-AZD4694, an Amyloid-β–Specific PET Radioligand

    Authors: Zsolt Cselényi, Maria Eriksdotter Jönhagen, Anton Forsberg, Christer Halldin, Per Julin, Magnus Schou, Peter Johnström, Katarina Varnäs, Samuel Svensson, Lars Farde - Journal of Nuclear Medicine 2012 cited by 223

  7. Brain exposure of the ATM inhibitor AZD1390 in humans—a positron emission tomography study

    Authors: Aurelija Jučaitė, Per Stenkrona, Zsolt Cselényi, Serena De Vita, Núria Buil‐Bruna, Katarina Varnäs, Alicia Savage, Andrea Varrone, Peter Johnström, Magnus Schou, Chris Davison, Andy Sykes, Venkatesh Pilla Reddy, Matthias Hoch, Ana Vázquez‐Romero, Mohammad Mahdi Moein, Christer Halldin, Melinda S. Merchant, Martin Pass, Lars Farde - Neuro-Oncology 2020 cited by 66

  8. The immune response of the human brain to abdominal surgery

    Authors: Anton Forsberg, Simon Červenka, Malin Jonsson Fagerlund, Lars S. Rasmussen, Henrik Zetterberg, Helena Erlandsson Harris, Pernilla Stridh, Eva Christensson, Anna Löf Granström, Anna Schening, Karin Dymmel, Nina Knave, Niccolò Terrando, Mervyn Maze, Jacqueline Borg, Andrea Varrone, Christer Halldin, Kaj Blennow, Lars Farde, Lars I. Eriksson - Annals of Neurology 2017 cited by 106

  9. Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine

    Authors: Lars Farde - Archives of General Psychiatry 1992 cited by 1,420

  10. Distribution of D1- and D2-Dopamine Receptors, and Dopamine and Its Metabolites in the Human Brain

    Authors: Håkan Hall, G. Sedvall, Olle Magnusson, Jutta Kopp, Christer Halldin, Lars Farde - Neuropsychopharmacology 1994 cited by 426

  11. Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand

    Authors: Anders Juréus, Britt‐Marie Swahn, Johan Sandell, Fredrik Jeppsson, Allan E. Johnson, Peter Johnström, Jan Neelissen, Dan Sunnemark, Lars Farde, Samuel Svensson - Journal of Neurochemistry 2010 cited by 140

  12. Changes in Cortical Dopamine D1 Receptor Binding Associated with Cognitive Training

    Authors: Fiona McNab, Andrea Varrone, Lars Farde, Aurelija Jučaitė, Paulina Bystritsky, Hans Forssberg, Torkel Klingberg - Science 2009 cited by 552

  13. The International Journal of Neuropsychopharmacology

    Authors: Bernard Lerer, Alan Frazer, Stephen M. Stahl, Lars Farde, P. Lesch - The International Journal of Neuropsychopharmacology 1998 cited by 506

  14. Age-Related Cognitive Deficits Mediated by Changes in the Striatal Dopamine System

    Authors: Lars Bäckman, Nathalie Ginovart, Roger A. Dixon, Tarja‐Brita Robins Wahlin, Åke Wåhlin, Christer Halldin, Lars Farde - American Journal of Psychiatry 2000 cited by 469

  15. Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning Analysis

    Authors: Aurelija Jučaitė, Zsolt Cselényi, William Charles Kreisl, Eugenii A. Rabiner, Andrea Varrone, Richard E. Carson, Juha O. Rinne, Alicia Savage, Magnus Schou, Peter Johnström, Per Svenningsson, Olivier Rascol, Wassilios G. Meissner, Paolo Barone, Klaus Seppi, Horacio Kaufmann, Gregor K. Wenning, Werner Poewe, Lars Farde - Movement Disorders 2021 cited by 41

  16. Nigrostriatal dopamine transporter availability in early Parkinson's disease

    Authors: Patrik Fazio, Per Svenningsson, Zsolt Cselényi, Christer Halldin, Lars Farde, Andrea Varrone - Movement Disorders 2018 cited by 101

  17. Serotonin transporter availability in adults with autism—a positron emission tomography study

    Authors: Max Andersson, Ämma Tangen, Lars Farde, Sven Bölte, Christer Halldin, Jacqueline Borg, Johan Lundberg - Molecular Psychiatry 2020 cited by 63

  18. Validity and reliability of extrastriatal [11C]raclopride binding quantification in the living human brain

    Authors: Jonas Svensson, Martin Schain, Pontus Plavén-Sigray, Simon Cervenka, Mikael Tiger, Magdalena Nord, Christer Halldin, Lars Farde, Johan Lundberg - NeuroImage 2019 cited by 51

  19. Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis

    Authors: Pontus Plavén‐Sigray, Pauliina Victorsson, Alexander Santillo, Granville J. Matheson, Maria Lee, Karin Collste, Helena Fatouros‐Bergman, Carl M. Sellgren, Sophie Erhardt, Ingrid Agartz, Christer Halldin, Lars Farde, Simon Červenka - Molecular Psychiatry 2021 cited by 30

  20. Decreased 5‐HT1A binding in mild Alzheimer's disease—A positron emission tomography study

    Authors: Patrik Mattsson, Zsolt Cselényi, Bengt Andrée, Jacqueline Borg, Sangram Nag, Christer Halldin, Lars Farde - Synapse 2022 cited by 15

  21. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients

    Authors: Anna Nordström, Lars Farde, Frits‐Axel Wiesel, Kaj Forslund, Stefan Pauli, Christer Halldin, Gunilla Uppfeldt - Biological Psychiatry 1993 cited by 530

  22. Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT

    Authors: Andrea Varrone, Nils Sjöholm, Lars Eriksson, Balázs Gulyás, Christer Halldin, Lars Farde - European Journal of Nuclear Medicine and Molecular Imaging 2009 cited by 206

  23. High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson’s disease cohort

    Authors: Patrik Fazio, Daniel Ferreira, Per Svenningsson, Christer Halldin, Lars Farde, Eric Westman, Andrea Varrone - European Journal of Nuclear Medicine and Molecular Imaging 2020 cited by 23

  24. Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic Drugs

    Authors: Lars Farde - Archives of General Psychiatry 1988 cited by 693